Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

Neuroblastoma is the most common extracranial solid tumor diagnosed in children. This inaugural version of the NCCN Guidelines for Neuroblastoma provides recommendations for the diagnosis, risk classification, and treatment of neuroblastoma. The information in these guidelines was developed by the NCCN Neuroblastoma Panel, a multidisciplinary group of representatives with expertise in neuroblastoma, consisting of pediatric oncologists, radiologists, pathologists, surgeons, and radiation oncologists from NCCN Member Institutions. The evidence-based and consensus recommendations contained in the NCCN Guidelines are intended to guide clinicians in selecting the most appropriate treatments for their patients with this clinically heterogeneous disease.

Authors

Institutions

Publication Details

Journal
Journal of the National Comprehensive Cancer Network
Published
2024-08-01
DOI
https://doi.org/10.6004/jnccn.2024.0040
Citations
40
Primary Topic
Neuroblastoma Research and Treatments
Type
article
Field-Weighted Citation Impact
14.76
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

Steven G. DuBois, Raja Rabah, Tanya Carens Watt, Elizabeth Sokol et al.
40 citations
Journal of the National Comprehensive Cancer Network
Neuroblastoma Research and Treatments
14.76
article

Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

Steven G. DuBois, Raja Rabah, Tanya Carens Watt, Elizabeth Sokol, Paul Iskander, Stephanie F. Polites, Julie R. Park, Erin G. Brown, Leonora R. Slatnick, Susan G. Kreissman, Clare J. Twist, Ami Vijay Desai, Rochelle Bagatell, Frederick S. Huang, Jenna Allison, Alanna J. Church, Margaret E. Macy, Lisa Hang, Andrew M. Davidoff, Ryan Schonfeld, Daniel J. Benedetti, Kieuhoa T. Vo, Jennifer H. Aldrink, Steve K. Cho, Peter E. Zage, Douglas Fair, Douglas J. Harrison, Brian S Na, Farzana Pashankar, Navin Pinto, Sahaja Acharya, Hiroyuki Shimada, Joaquim Farinhas, Suzanne Wolden, Carola Arndt, Elizabeth Alva, Praveen Pendyala
article en
40 citations

Abstract

Neuroblastoma is the most common extracranial solid tumor diagnosed in children. This inaugural version of the NCCN Guidelines for Neuroblastoma provides recommendations for the diagnosis, risk classification, and treatment of neuroblastoma. The information in these guidelines was developed by the NCCN Neuroblastoma Panel, a multidisciplinary group of representatives with expertise in neuroblastoma, consisting of pediatric oncologists, radiologists, pathologists, surgeons, and radiation oncologists from NCCN Member Institutions. The evidence-based and consensus recommendations contained in the NCCN Guidelines are intended to guide clinicians in selecting the most appropriate treatments for their patients with this clinically heterogeneous disease.

Journal of the National Comprehensive Cancer NetworkVol. 22(6)
Roswell Park Comprehensive Cancer Center (US), Lurie Children's Hospital (US), Seattle Children's Hospital (US), Children's Medical Center (US), Monroe Carell Jr. Children's Hospital (US), Barnes-Jewish Hospital (US), St. Jude Children's Research Hospital (US), Nationwide Children's Hospital (US), Cleveland Clinic (US), St. Louis Children's Hospital (US), Primary Children's Hospital (US), Lucile Packard Children's Hospital (US), Memorial Sloan Kettering Cancer Center (US), Children's Hospital of Philadelphia (US), The University of Texas MD Anderson Cancer Center (US), Johns Hopkins University (US), University of Tennessee Health Science Center (US), University of Utah (US), The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US), Huntsman Cancer Institute (US), Cancer Institute (WIA) (IN), Susan Thompson Buffett Foundation (US), WinnMed (US), Yale Cancer Center (US), Moffitt Cancer Center (US), Children's of Alabama (US), University of California San Diego (US), Rady Children's Hospital-San Diego (US), Fred Hutch Cancer Center (US), Children's Hospital Colorado (US), Jewish Hospital (US), Sidney Kimmel Cancer Center (US), University Hospitals Seidman Cancer Center (US), Johns Hopkins Children's Center (US), Duke Children's Hospital & Health Center (US), University of Colorado Cancer Center (US), Mattel Children's Hospital (US), UCSF Benioff Children's Hospital (US), University of Wisconsin American Family Children's Hospital (US), Children's Hospital & Medical Center (US), Children's Cancer Center (US), C. S. Mott Children's Hospital (US), Dana-Farber Brigham Cancer Center (US), Dana-Farber/Boston Children's Cancer and Blood Disorders Center (US), UCSF Helen Diller Family Comprehensive Cancer Center (US), University of Chicago Medicine Comprehensive Cancer Center, UC Davis Comprehensive Cancer Center, National Comprehensive Cancer Network, University of Pennsylvania (US), University of California, Davis (US), The University of Texas Southwestern Medical Center (US), University of Colorado Denver (US)
Good health and well-being
Openalex Percentile: Top 1%
Neuroblastoma Research and Treatments
14.76
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.